ArticleEmerging microbes & infections2020
Genomic epidemiology of emerging ESBL-producing
Article in Emerging microbes & infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 49 citations in OpenAlex.
- Emergence of azithromycin-resistant extensively drug-resistantFrontiers in microbiology · 2026Article
- The emergence of chromosomally locatedFrontiers in microbiology · 2026Article
- Prevalence and whole genome sequencing analysis of Salmonella isolated from a homebred chicken farm in Jiangsu province.Frontiers in veterinary science · 2026Article
- Clonal spread of multidrug-resistant Salmonella Kentucky ST198 in poultry market environments in Dhaka city, Bangladesh.PloS one · 2026Article
- Global genomic survey ofEmerging microbes & infections · 2025Article
- Genomic characterisation of multidrug-resistantMicrobial genomics · 2025Article
- Temporal reconstruction of aMicrobial genomics · 2025Article
- Article
- Genomics for antimicrobial resistance-progress and future directions.Antimicrobial agents and chemotherapy · 2025Review
- Refractory Nontyphoidal Salmonella Empyema Necessitans in a Man Living With HIV: A Case Report and Review of the Literature.Case reports in infectious diseases · 2025Article
- A novel variant inMicrobiology spectrum · 2024Article
- Dissemination of Ceftriaxone-ResistantAntibiotics (Basel, Switzerland) · 2024Article
- The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2021-2022.EFSA journal. European Food Safety Authority · 2024Article
- Persistent Colonization of Ciprofloxacin-Resistant and Extended-Spectrum β-Lactamase (ESBL)-ProducingInfection and drug resistance · 2024Article
- Article
- Genomic analysis of almost 8,000Microbiology spectrum · 2023Article
- Whole-Genome Sequencing Analysis of Non-TyphoidalAntibiotics (Basel, Switzerland) · 2023Article
- Characterization of extended spectrum β-lactamases in Colombian clinical isolates of non-typhoidal Salmonella enterica between 1997 and 2022Biomedica : revista del Instituto Nacional de Salud · 2023Article
- Highly drug resistant clone of Salmonella Kentucky ST198 in clinical infections and poultry in Zimbabwe.npj antimicrobials and resistance · 2023Article
- The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021.EFSA journal. European Food Safety Authority · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 5 institutions in 6 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Global dissemination of ciprofloxacin-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.